Cyclosporin-induced downregulation of the expression of E-cadherin during proliferation of edentulous gingival epithelium in rats

Journal of Periodontology

Volumn 77, Issue 5, 2006, Pages 832-839

  Tu, Hsiao Pei ^a,b   Chen, Yen Teen ^b,c   Shieh, Yi Shing ^c   Chin, Yu Tang ^b   Huang, Ren Yeong ^b   Yang, Shih Fang ^a   Gau, Ching Hwa ^d   Fu, Earl ^b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d Kang Ning Junior College of Medical Care and Management   (Taiwan)

Author keywords

Adverse effects; Cyclosporin; E cadherin; Gingiva

Indexed keywords

BETA CATENIN; CYCLIN D1; CYCLINE; CYCLOSPORIN A; MESSENGER RNA; UVOMORULIN; CADHERIN; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; EDENTULOUSNESS; EPITHELIUM CELL; GINGIVA HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MALE; MOLAR TOOTH; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; EPITHELIUM; GENE EXPRESSION; GINGIVA; METABOLISM; MOUTH DISEASE;

ANIMALS; BETA CATENIN; CADHERINS; CYCLIN D1; CYCLOSPORINE; DOWN-REGULATION; EPITHELIUM; GENE EXPRESSION; GINGIVA; GINGIVAL HYPERPLASIA; IMMUNOSUPPRESSIVE AGENTS; MALE; MOUTH, EDENTULOUS; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RNA, MESSENGER;

EID: 33746023324     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2006.050316     Document Type: Article

References (55)

1. Rateitschak-Pluss EM, Hefti A, Lortscher R, Thiel G. Initial observation that cyclosporin-A induces gingival enlargement in man. J Clin Periodontol 1983;10:237-246.
2. Deliliers GL, Santoro F, Polli N, Bruno E, Fumagalli L, Risciotti E. Light and electron microscopic study of cyclosporin A-induced gingival hyperplasia. J Periodontol 1986;57:771-775.
3. Wysocki GP, Gretzinger HA, Laupacis A, Ulan RA, Stiller CR. Fibrous hyperplasia of the gingiva: A side effect of cyclosporin A therapy. Oral Surg Oral Med Oral Pathol 1983;55:274-278.
4. Schincaglia GP, Forniti F, Cavallini R, Piva R, Calura G, del Senno L. Cyclosporin-A increases type I procollagen production and mRNA level in human gingival fibroblasts in vitro. J Oral Pathol Med 1992;21:181-185.
5. Zebrowski EJ, Pylypas SP, Odlum O, Johnson RB. Comparative metabolism of 3H-glucosamine by fibroblast populations exposed to cyclosporine. J Periodontol 1994;65:565-567.
6. Bartold PM. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodontol Res 1989;24:314-321.
7. Tipton DA, Stricklin GP, Dabbous MK. Fibroblast heterogeneity in collagenolytic response to cyclosporine. J Cell Biochem 1991;46:152-165.
8. Tipton DA, Pabst MJ, Dabbous MK. Interleukin-1 beta- and tumor necrosis factor-alpha-independent monocyte stimulation of fibroblast collagenase activity. J Cell Biochem 1990;44:253-264.
9. Bolcato-Bellemin AL, Elkaim R, Tenenbaum H. Expression of RNAs encoding for alpha and beta integrin subunits in periodontitis and in cyclosporin A gingival overgrowth. J Clin Periodontol 2003;30:937-943.
10. Nurmenniemi PK, Pernu HE, Knuuttila ML. Mitotic activity of keratinocytes in nifedipine- and immunosuppressive medication-induced gingival overgrowth. J Periodontol 2001;72:167-173.
11. Fu E, Hsieh YD, Shen EC, Nieh S, Mao TK, Chiang CY. Cyclosporin-induced gingival overgrowth at the newly formed edentulous ridge in rats: A morphological and histometric evaluation. J Periodontol 2001;72:889-894.
12. Das SJ, Parkar MH, Olsen I. Upregulation of keratinocyte growth factor in cyclosporin A-induced gingival overgrowth. J Periodontol 2001;72:745-752.
13. Hyland PL, McKeown ST, Mackenzie IC, Irwin CR. Regulation of keratinocyte growth factor and scatter factor in cyclosporin-induced gingival overgrowth. J Oral Pathol Med 2004;33:391-397.
14. Conacci-Sorrell M, Zhurinsky J, Ben-Ze'ev A. The cadherin-catenin adhesion system in signaling and cancer. J Clin Invest 2002;109:987-991.
15. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004;303: 1483-1487.
16. Batlle E, Sancho E, Franci C, et al. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000;2: 84-89.
17. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2000;2:76-83.
18. Hajra KM, Chen DY, Fearon ER. The SLUG zinc-finger protein represses E-cadherin in breast cancer. Cancer Res 2002;62:1613-1618.
19. Gasparoni A, Chaves A, Fonzi L, Johnson GK, Schneider GB, Squier CA. Subcellular localization of β-catenin in malignant cell lines and squamous cell carcinomas of the oral cavity. J Oral Pathol Med 2002;31:385-394.
20. Wheelock MJ, Soler AP, Knudsen KA. Cadherin junctions in mammary tumors. J Mammary Gland Biol Neoplasia 2001;6:275-285.
21. Pernu HE, Pernu LM, Huttunen KR, Nieminen PA, Knuuttila ML. Gingival overgrowth among renal transplant recipients related to immunosuppressive medication and possible local background factors. J Periodontol 1992;63:548-553.
22. Seymour RA, Smith DG. The effect of a plaque control programme on the incidence and severity of cyclosporin-induced gingival changes. J Clin Periodontol 1991;18:107-110.
23. Takahashi K, Lappin D, Kinane DF. In situ localization of cell synthesis and proliferation in periodontitis gingiva and tonsillar tissue. Oral Dis 1996;2:210-216.
24. Birkedal-Hansen H. Role of cytokines and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28:500-510.
25. Alvarez-Arroyo MV, Yague S, Wenger RM, et al. Cyclophilin-mediated pathways in the effect of cyclosporin A on endothelial cells: Role of vascular endothelial growth factor. Circ Res 2002;91:202-209.
26. Sheibani N, Sorenson CM, Frazier WA. Differential modulation of cadherin-mediated cell-cell adhesion by platelet endothelial cell adhesion molecule-1 isoforms through activation of extracellular regulated kinases. Mol Biol Cell 2000;11:2793-2802.
27. Miyoshi K, Shillingford JM, Smith GH, et al. Signal transducer and activator of transcription (Stat) 5 controls the proliferation and differentiation of mammary alveolar epithelium. J Cell Biol 2001;155:531-542.
28. Tateishi K, Omata M, Tanaka K, Chiba T. The NEDD8 system is essential for cell cycle progression and morphogenetic pathway in mice. J Cell Biol 2001;155: 571-579.
29. Ewen ME, Sluss HK, Sherr CJ, Matsushime H, Kato J, Livingston DM. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 1993;73:487-497.
30. Kiyokawa H, Busquets X, Powell CT, Ngo L, Rifkind RA, Marks PA. Cloning of a D-type cyclin from murine erythroleukemia cells. Proc Natl Acad Sci USA 1992; 89:2444-2447.
31. Hong R, Chakravarti D. The human proliferating cell nuclear antigen regulates transcriptional coactivator p300 activity and promotes transcriptional repression. J Biol Chem 2003;278:44505-44513.
32. Bravo R, Macdonald-Bravo H. Existence of two populations of cyclin/ proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 1987;105:1549-1554.
33. Takeuchi M, Yamamoto M, Tatematsu M, Miki K, Sakaki Y, Furihata C. Dendritic cell appearance and differentiation during early and late stages of rat stomach carcinogenesis. Jpn J Cancer Res 2002;93: 925-934.
34. Yue SQ, Yang YL, Dou KF, Li KZ. Expression of PCNA and CD44mRNA in colorectal cancer with venous invasion and its relationship to liver metastasis. World J Gastroenterol 2003;9:2863-2865.
35. Kulka M, Schwingshackl A, Befus AD. Mast cells express chloride channels of the CIC family. Inflamm Res 2002;51:451-456.
36. Vigo E, Muller H, Prosperini E, et al. CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase. Mol Cell Biol 1999;19:6379-6395.
37. Chung SS, Lee WM, Cheng CY. Study on the formation of specialized inter-Sertoli cell junctions in vitro. J Cell Physiol 1999;181:258-272.
38. Jang YJ, Kim HG, Koo TW, Chung PS. Localization of ZO-1 and E-cadherin in the nasal polyp epithelium. Eur Arch Otorhinolaryngol 2002;259:465-469.
39. Wong AS, Gumbiner BM. Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol 2003;161:1191-1203.
40. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002;2:442-454.
41. Hirohashi S. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 1998;153:333-339.
42. Meniel V, Clarke AR. Wnt-cadherin connections in normal and neoplastic mammary epithelium. J Mammary Gland Biol Neoplasia 2003;8:435-447.
43. Odajima T, Sasaki Y, Tanaka N, et al. Abnormal β-catenin expression in oral cancer with no gene mutation: Correlation with expression of cyclin D1 and epidermal growth factor receptor, Ki-67 labeling index, and clinicopathological features. Hum Pathol 2005;36:234-241.
44. Honda H, Barloon TJ, Franken EA Jr., Garneau RA, Smith JL. Clinical and radiologic features of malignant neoplasms in organ transplant recipients: Cyclosporine-treated vs untreated patients. AJR Am J Roentgenol 1990;154:271-274.
45. Blohme I, Larko O. No difference in skin cancer incidence with or without cyclosporine - A 5-year perspective. Transplant Proc 1992;24:313.
46. Couetil JP, McGoldrick JP, Wallwork J, English TA. Malignant tumors after heart transplantation. J Heart Transplant 1990;9:622-626.
47. Demarosi F, Soligo D, Lodi G, Moneghini L, Sardella A, Carrassi A. Squamous cell carcinoma of the oral cavity associated with graft versus host disease: Report of a case and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:63-69.
48. Harris TJ, Peifer M. Decisions, decisions: β-Catenin chooses between adhesion and transcription. Trends Cell Biol 2005;15:234-237.
49. Yook JI, Li XY, Ota I, Fearon ER, Weiss SJ. Wnt-dependent regulation of the E-cadherin repressor snail. J Biol Chem 2005;280:11740-11748.
50. Lu Z, Hunter T. Wnt-independent β-catenin transactivation in tumor development. Cell Cycle 2004;3: 571-573.
51. Anna CH, Iida M, Sills RC, Devereux TR. Expression of potential beta-catenin targets, cyclin D1, c-Jun, c-Myc, E-cadherin, and EGFR in chemically induced hepatocellular neoplasms from B6C3F1 mice. Toxicol Appl Pharmacol 2003;190:135-145.
52. Saito T, Oda Y, Tanaka K, et al. Beta-catenin nuclear expression correlates with cyclin D1 overexpression in sporadic desmoid tumours. J Pathol 2001;195: 222-228.
53. He X. Wnt-Wnt situation. Dev Cell 2003;4:791-797.
54. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
55. Shtutman M, Zhurinsky J, Oren M, Levina E, Ben-Ze'ev A. PML is a target gene of beta-catenin and plakoglobin, and coactivates beta-catenin-mediated transcription. Cancer Res 2002;62:5947-5954.